Business Context and Reporting Period
This Form 8-K was filed by MultiPlan Corporation, although the request identifies Claritev Corp. The report is dated January 31, 2022, and concerns executive succession, board changes, and related compensation arrangements. It does not report quarterly or annual financial results.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating or balance-sheet metrics.
Material Changes Versus Prior Period
- Mark Tabak resigned as Chief Executive Officer effective January 31, 2022, citing a previously approved succession plan. He remained Chairman of the Board.
- Dale White, previously President and Chief Operating Officer, was appointed Chief Executive Officer and President and joined the Board as a Class III director.
- The Board increased from 11 to 12 directors and created the role of Non-Executive Chairman.
- Mr. White’s prior employment agreement was replaced with a new agreement beginning January 31, 2022, with an initial three-year term and automatic one-year renewals.
Guidance, Outlook, Risks, and Unusual Items
- Mr. White’s annual base salary is $750,000, with a target annual bonus equal to 125% of base salary.
- Beginning in 2022, Mr. White is eligible for annual equity awards with a grant-date fair value of at least $6.0 million, subject to the Compensation Committee’s determinations.
- Following the February 2022 earnings release, the Company is required to grant stock options with an aggregate Black-Scholes value of $3.0 million, allocated among exercise prices of $7.50, $10.00, and $12.50.
- Specified termination without cause, resignation for good reason, or certain non-renewals may trigger severance equal to 1.5 times salary plus target bonus, a prorated bonus payment, and up to 18 months of COBRA coverage, subject to conditions.
- Mr. White is subject to non-competition and non-solicitation restrictions during employment and for 18 months afterward, along with indefinite confidentiality and non-disparagement obligations.
- The filing states that Mr. Tabak’s resignation was not due to disagreement with the Company, management, or the Board. No business outlook or financial guidance was provided.
Important Facts to Verify
- Confirm the applicable registrant name: the filing identifies MultiPlan Corporation, not Claritev Corp.
- Review the full employment agreement, Investor Rights Agreement amendment, and stock award agreement filed as Exhibits 10.1 through 10.3.
- Verify the actual valuation, terms, and dilution effects of the planned $3.0 million stock-option grant.
- Assess the potential future compensation, severance, and equity expense associated with the CEO transition.
- Review subsequent filings for implementation of the succession plan, board composition, and any changes to the stated compensation arrangements.